Related Experiment Videos
Dendritic cell endothelium interaction in autoimmunity.
C L Schlichting1, W D Schareck, M Weis
1Department of Surgery, Devision of Transplantation Surgery, School of Medicine, University Hospital, University Rostock, Schillingalle 35, 18055 Rostock, Germany. christoph.schlichting@drschlichting.de
Current Pharmaceutical Design
|February 3, 2004
Summary
Monocyte-derived dendritic cells (moDCs) are key immune activators. This review models how moDCs in lymph nodes activate auto-reactive T-cells, crucial for understanding autoimmune diseases.
Area of Science:
- Immunology
- Cell Biology
Background:
- Monocyte-derived dendritic cells (moDCs) are crucial for initiating adaptive immune responses by activating T lymphocytes.
- moDCs differentiate from monocytes after transmigration across the endothelium and play a vital role in antigen presentation.
Purpose of the Study:
- To develop a model for the in vivo activation of auto-reactive T-cells by dendritic cells.
- To elucidate the mechanisms of dendritic cell migration and T-cell activation in the context of autoimmunity.
Main Methods:
- Review of existing literature on monocyte differentiation, dendritic cell migration, and T-cell activation.
- Conceptual modeling of dendritic cell trafficking from blood to lymph nodes and subsequent T-cell interaction.
Main Results:
- Dendritic cells engulf tissue antigens and migrate to lymph nodes.
- In lymph nodes, dendritic cells traffic to T-cell areas to activate T-cells.
- The review proposes a model for how activated dendritic cells can trigger auto-reactive T-cell responses.
Conclusions:
- Dendritic cell migration and antigen presentation are critical steps in T-cell activation.
- Understanding these processes is essential for developing strategies to control auto-reactive T-cell responses in autoimmune diseases.